English– category –
FDA Weekly Intelligence Report (English)
-
FDA Weekly Report 9/21-27
Members: skip the article and download now TROY INTELLIGENCE FDA Weekly Briefing / EN Edition DOC. NO. TI-EN-2026-W39 ISSUE 39 / 2026-09-21 — 2026-09-27 FDA Weekly Report 9/21–9/27: 7 new drug approvals (4 new molecular entit... -
FDA Weekly Report 9/14-20
Members: skip the article and download now TROY INTELLIGENCE FDA Weekly Briefing / EN Edition DOC. NO. TI-EN-2026-W38 ISSUE 38 / 2026-09-14 — 2026-09-20 FDA Weekly Report 9/14–9/20: 2 new drug approvals (1 novel CBER biologic... -
FDA Weekly Report 9/9-15
Members: skip the article and download now TROY INTELLIGENCE FDA Weekly Briefing / EN Edition DOC. NO. TI-EN-2026-W38-0909 ISSUE 38-0909 / 2026-09-09 — 2026-09-15 FDA Weekly Report 9/9–9/15: 3 new drug approvals (2 new molecu... -
FDA Weekly Report 9/2-8
Members: skip the article and download now TROY INTELLIGENCE FDA Weekly Briefing / EN Edition DOC. NO. TI-EN-2026-W37 ISSUE 37 / 2026-09-02 — 2026-09-08 FDA Weekly Report 9/2–9/8: 3 new drug approvals (2 new molecular entitie... -
FDA Weekly Report 8/27-9/1
Members: skip the article and download now TROY INTELLIGENCE FDA Weekly Briefing / EN Edition DOC. NO. TI-EN-2026-W36 ISSUE 36 / 2026-08-27 — 2026-09-01 FDA Weekly Report 8/27–9/1: 4 new drug approvals (2 new molecular entiti... -
FDA Weekly Report 8/20-26
Members: skip the article and download now TROY INTELLIGENCE FDA Weekly Briefing / EN Edition DOC. NO. TI-EN-2026-W35 ISSUE 35 / 2026-08-20 — 2026-08-26 BeiGene's PD-1 Inhibitor Tevimbra Finally Secures FDA Approval The long-... -
FDA Weekly Report 8/13-19
For subscribers: download now without reading the article TROY INTELLIGENCEFDA Weekly Briefing · English Edition DOC. NO. TI-EN-2026-W34 ISSUE 34 / 2026-08-13 — 2026-08-19 BMS Wins Approval for New Molecular Entity Iberdomide... -
FDA Weekly Report 8/6-8/12
For subscribers: download now without reading the article TROY INTELLIGENCEFDA Weekly Briefing · English Edition DOC. NO. TI-EN-2026-W33 ISSUE 33 / 2026-08-06 — 2026-08-12 Zero New Drugs This Week, But a Class I Recall Expose... -
FDA Weekly Report 7/30-8/5
TROY INTELLIGENCEFDA Weekly Briefing · English Edition DOC. NO. TI-EN-2026-W32 ISSUE 32 / 2026-07-30 — 2026-08-05 Takeda's ORZEYFUL Cleared, But Can't Ship Yet — Asian Firms Log 32 FDA Actions This Week Takeda's narcolepsy dr...
1